549 related articles for article (PubMed ID: 30974836)
1. Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention.
Gross EC; Klement RJ; Schoenen J; D'Agostino DP; Fischer D
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30974836
[TBL] [Abstract][Full Text] [Related]
2. The Ketogenic Diet in the Prevention of Migraines in the Elderly.
Fila M; Chojnacki J; Pawlowska E; Sobczuk P; Chojnacki C; Blasiak J
Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068855
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological Abnormalities in Migraine Ameliorated by Ketosis: A Proof-of-Concept Review.
Huynh P; Calabrese P
J Integr Neurosci; 2022 Oct; 21(6):167. PubMed ID: 36424743
[TBL] [Abstract][Full Text] [Related]
4. Ketone bodies in cell physiology and cancer.
Giuliani G; Longo VD
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C948-C963. PubMed ID: 38189128
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Cellular Biochemistry, Epigenetics and Metabolomics by Ketone Bodies. Implications of the Ketogenic Diet in the Physiology of the Organism and Pathological States.
Dąbek A; Wojtala M; Pirola L; Balcerczyk A
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32192146
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases.
Jang J; Kim SR; Lee JE; Lee S; Son HJ; Choe W; Yoon KS; Kim SS; Yeo EJ; Kang I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203294
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer.
Hwang CY; Choe W; Yoon KS; Ha J; Kim SS; Yeo EJ; Kang I
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432618
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.
Bolesławska I; Kowalówka M; Bolesławska-Król N; Przysławski J
Viruses; 2023 May; 15(6):. PubMed ID: 37376562
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
10. Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?
Simeone TA; Simeone KA; Stafstrom CE; Rho JM
Neuropharmacology; 2018 May; 133():233-241. PubMed ID: 29325899
[TBL] [Abstract][Full Text] [Related]
11. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
[TBL] [Abstract][Full Text] [Related]
12. Nutritional Ketosis with Ketogenic Diets or Exogenous Ketones: Features, Convergence, and Divergence.
Poff AM; Koutnik AP; Egan B
Curr Sports Med Rep; 2020 Jul; 19(7):251-259. PubMed ID: 32692060
[TBL] [Abstract][Full Text] [Related]
13. Common and divergent molecular mechanisms of fasting and ketogenic diets.
Paoli A; Tinsley GM; Mattson MP; De Vivo I; Dhawan R; Moro T
Trends Endocrinol Metab; 2024 Feb; 35(2):125-141. PubMed ID: 38577754
[TBL] [Abstract][Full Text] [Related]
14. Modulation of beta-hydroxybutyrate in traumatic brain injury.
Arora N; Shastri DH; Patel UP; Bhatia K
Curr Opin Clin Nutr Metab Care; 2024 Mar; 27(2):168-177. PubMed ID: 38170686
[TBL] [Abstract][Full Text] [Related]
15. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.
Hashim SA; VanItallie TB
J Lipid Res; 2014 Sep; 55(9):1818-26. PubMed ID: 24598140
[TBL] [Abstract][Full Text] [Related]
16. Neuroketotherapeutics: A modern review of a century-old therapy.
Koppel SJ; Swerdlow RH
Neurochem Int; 2018 Jul; 117():114-125. PubMed ID: 28579059
[TBL] [Abstract][Full Text] [Related]
17. The metabolic face of migraine - from pathophysiology to treatment.
Gross EC; Lisicki M; Fischer D; Sándor PS; Schoenen J
Nat Rev Neurol; 2019 Nov; 15(11):627-643. PubMed ID: 31586135
[TBL] [Abstract][Full Text] [Related]
18. [Ketone Body Metabolism and Renal Diseases].
Liu Y; Ma L; Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1091-1096. PubMed ID: 38162055
[TBL] [Abstract][Full Text] [Related]
19. Ketone Bodies as Metabolites and Signalling Molecules at the Crossroad between Inflammation and Epigenetic Control of Cardiometabolic Disorders.
Bendridi N; Selmi A; Balcerczyk A; Pirola L
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498891
[TBL] [Abstract][Full Text] [Related]
20. Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms.
Sridharan B; Lee MJ
Curr Mol Med; 2022; 22(7):640-656. PubMed ID: 34607541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
